Apontis Pharma AG

XETRA APPH.DE

Apontis Pharma AG Free Cash Flow for the year ending December 31, 2023: USD -17.50 M

Apontis Pharma AG Free Cash Flow is USD -17.50 M for the year ending December 31, 2023, a -311.31% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
  • Apontis Pharma AG Free Cash Flow for the year ending December 31, 2022 was USD 8.28 M, a 310.31% change year over year.
  • Apontis Pharma AG Free Cash Flow for the year ending December 31, 2021 was USD 2.02 M, a 129.07% change year over year.
  • Apontis Pharma AG Free Cash Flow for the year ending December 31, 2020 was USD 881.30 K, a 160.95% change year over year.
  • Apontis Pharma AG Free Cash Flow for the year ending December 31, 2019 was USD -1.45 M.
Key data
Date Free Cash Flow Operating Cash Flow Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities
Market news
SV Wall Street
XETRA: APPH.DE

Apontis Pharma AG

CEO Mr. Bruno Wohlschlegel
IPO Date May 11, 2021
Location Germany
Headquarters Alfred-Nobel-Str. 10
Employees 177
Sector Healthcare
Industries
Pharmaceuticals Drugstores & Retail Pharmacies
Description

Apontis Pharma AG markets and sells medical drugs for indication fields of internal medicine in Germany. It develops, promotes, and sells a portfolio of single pills and other pharmaceutical products with a focus on cardiovascular diseases, such as hypertension, hyperlipidemia, and secondary prevention, as well as respiratory diseases and diabetes. The company was founded in 1946 is headquartered in Monheim am Rhein, Germany.

StockViz Staff

February 6, 2025

Any question? Send us an email